Kare-in-home Hospice, Llc 936 Hall Street, Suite F&g,, Wiggins, MS, 39577 | |
(601) 799-2088 |
News Archive
While many parents painstakingly inspect the pounds of sugary loot brought home each Halloween, they need to keep in mind that candy tampering isn't the largest concern they face.
Research released today shows that scientists are finding new tools to help understand neurodevelopmental disorders like autism and fragile X syndrome. These studies show in new detail how the brain's connections, chemicals, and genes interact to affect behavior.
OncoGenex Pharmaceuticals, Inc. announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5.
A new test may soon be available to predict advanced fibrosis in people with non-alcoholic fatty liver disease.
› Verified 5 days ago
Name | Kare-in-home Hospice, Llc |
---|---|
Location | 936 Hall Street, Suite F&g,, Wiggins, Mississippi |
Hospice ID | 251684 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Individual |
Profit Type | FOR PROFIT |
SSA county code | 650 |
News Archive
While many parents painstakingly inspect the pounds of sugary loot brought home each Halloween, they need to keep in mind that candy tampering isn't the largest concern they face.
Research released today shows that scientists are finding new tools to help understand neurodevelopmental disorders like autism and fragile X syndrome. These studies show in new detail how the brain's connections, chemicals, and genes interact to affect behavior.
OncoGenex Pharmaceuticals, Inc. announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5.
A new test may soon be available to predict advanced fibrosis in people with non-alcoholic fatty liver disease.
› Verified 5 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.1 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 91.3 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 90.4 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 98.4 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 97.4 | 97.3 |
Patients who got timely treatment for shortness of breath | 90.9 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 95.0 | 93.3 |
News Archive
While many parents painstakingly inspect the pounds of sugary loot brought home each Halloween, they need to keep in mind that candy tampering isn't the largest concern they face.
Research released today shows that scientists are finding new tools to help understand neurodevelopmental disorders like autism and fragile X syndrome. These studies show in new detail how the brain's connections, chemicals, and genes interact to affect behavior.
OncoGenex Pharmaceuticals, Inc. announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5.
A new test may soon be available to predict advanced fibrosis in people with non-alcoholic fatty liver disease.
› Verified 5 days ago
Home Health Aides | 4 |
Counselors | 1 |
Medical Social Workers | 1 |
Physicians | 4 |
Registered Nurses | 9 |
Other Personnel | 1 |
Total Employees | 20 |
---|
News Archive
While many parents painstakingly inspect the pounds of sugary loot brought home each Halloween, they need to keep in mind that candy tampering isn't the largest concern they face.
Research released today shows that scientists are finding new tools to help understand neurodevelopmental disorders like autism and fragile X syndrome. These studies show in new detail how the brain's connections, chemicals, and genes interact to affect behavior.
OncoGenex Pharmaceuticals, Inc. announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5.
A new test may soon be available to predict advanced fibrosis in people with non-alcoholic fatty liver disease.
› Verified 5 days ago
Others | 17 |
Total Volunteers | 17 |
---|
News Archive
While many parents painstakingly inspect the pounds of sugary loot brought home each Halloween, they need to keep in mind that candy tampering isn't the largest concern they face.
Research released today shows that scientists are finding new tools to help understand neurodevelopmental disorders like autism and fragile X syndrome. These studies show in new detail how the brain's connections, chemicals, and genes interact to affect behavior.
OncoGenex Pharmaceuticals, Inc. announced today data from a Phase 2 study of its investigational compound OGX-427 in chemotherapy-naive metastatic castration resistant prostate cancer (mCRPC) patients will be presented during an oral presentation at the 2012 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday, June 5.
A new test may soon be available to predict advanced fibrosis in people with non-alcoholic fatty liver disease.
› Verified 5 days ago
Kare-in-home Hospice, Llc Location: 936 Hall Street, Suite F&g,, Wiggins, Mississippi, 39577 Phone: (601) 799-2088 |
Southern Hearts Hospice Location: 713 Hall Street, Wiggins, Mississippi, 39577 Phone: (601) 799-2088 |